Related Experiment Videos
[AIDS-related malignant lymphoma]
1Division of Infectious Diseases and Applied Immunology, University of Tokyo.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 31, 2000
Summary
Japanese patients with HIV-1 infection have a high risk of developing AIDS lymphoma, predominantly Epstein-Barr virus (EBV)-related non-Hodgkin's lymphoma. This differs from Western cases, suggesting variations in EBV prevalence may influence lymphoma subtypes and CD4 counts.
Area of Science:
- Oncology
- Virology
- Immunology
Context:
- Patients with Human Immunodeficiency Virus type 1 (HIV-1) infection face an elevated risk of malignant lymphoma, commonly referred to as acquired immunodeficiency syndrome (AIDS) lymphoma.
- In Japan, over 90% of AIDS lymphoma cases are associated with Epstein-Barr virus (EBV).
Purpose:
- To characterize the clinical and histological features of AIDS lymphoma in Japanese patients.
- To compare these features with those reported in the United States and Europe.
Summary:
- The study analyzed 22 Japanese AIDS lymphoma cases, all classified as non-Hodgkin's lymphoma (diffuse large or diffuse immunoblastic types).
- The mean CD4 count in these patients was notably low at 13.6/mm³.
- This contrasts with Western reports where approximately 50% of AIDS lymphoma cases are small noncleaved type with a mean CD4 count around 200/mm³.
Impact:
- Findings suggest significant differences in AIDS lymphoma characteristics between Japan and Western countries.
- The study highlights the potential role of EBV prevalence in driving these variations, although the precise reasons remain unclear.
- Further research is needed to elucidate the epidemiological and etiological factors contributing to these observed differences in AIDS lymphoma.